• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

扩张型心肌病中心肌Ⅰ型和Ⅲ型胶原mRNA丰度的差异:心肌炎症的影响。

Differential myocardial abundance of collagen type I and type III mRNA in dilated cardiomyopathy: effects of myocardial inflammation.

作者信息

Pauschinger M, Doerner A, Remppis A, Tannhäuser R, Kühl U, Schultheiss H P

机构信息

Department of Cardiology, Universitätsklinikum Benjamin Franklin, Freien Universität Berlin, Germany.

出版信息

Cardiovasc Res. 1998 Jan;37(1):123-9. doi: 10.1016/s0008-6363(97)00217-4.

DOI:10.1016/s0008-6363(97)00217-4
PMID:9539866
Abstract

OBJECTIVE

The collagen subtypes I (Col I) and III (Col III) are essential components of the cardiac extracellular matrix (ECM) maintaining the functional integrity of the heart. Histological, immunohistological, and biochemical studies, however, demonstrate characteristical changes of the ECM in dilated cardiomyopathy, myocarditis, ischemic cardiomyopathy, and hypertensive heart disease.

METHODS

In order to investigate possible effects of inflammatory processes on mRNA abundance of Col I and Col III, we examined 24 patients with the presumptive clinical diagnosis of dilated cardiomyopathy (EF = 30 +/- 11%). 12 Patients were classified as idiopathic dilated cardiomyopathy without any evidence of myocardial inflammation; the remaining 12 patients were classified as inflammatory cardiomyopathy due to the immunohistologically documented inflammatory myocardial process.

RESULTS

Quantification of reverse transcription polymerase chain reaction (RT-PCR) products revealed significant differences as to the mRNA abundance ratio Col III/Col I between subgroups of patients with inflammatory cardiomyopathy (1.16 +/- 0.18) and idiopathic dilated cardiomyopathy (2.77 +/- 0.65) regardless of left ventricular dysfunction (p < or = 0.05).

CONCLUSION

It is not yet known, whether different Col III/Col I ratios differentially influence diastolic compliance. Our data suggest that inflammatory mechanisms seen in inflammatory cardiomyopathy influence the mRNA abundance of collagen subtypes I and III.

摘要

目的

I型胶原(Col I)和III型胶原(Col III)是心脏细胞外基质(ECM)的重要组成部分,维持着心脏的功能完整性。然而,组织学、免疫组织学和生化研究表明,在扩张型心肌病、心肌炎、缺血性心肌病和高血压性心脏病中,ECM存在特征性变化。

方法

为了研究炎症过程对Col I和Col III mRNA丰度的可能影响,我们检查了24例临床初步诊断为扩张型心肌病(EF = 30±11%)的患者。12例患者被归类为特发性扩张型心肌病,无任何心肌炎症证据;其余12例患者因免疫组织学记录的炎症性心肌过程而被归类为炎症性心肌病。

结果

逆转录聚合酶链反应(RT-PCR)产物定量显示,炎症性心肌病患者亚组(1.16±0.18)和特发性扩张型心肌病患者亚组(2.77±0.65)之间,无论左心室功能障碍情况如何,Col III/Col I mRNA丰度比均存在显著差异(p≤0.05)。

结论

不同的Col III/Col I比值是否对舒张期顺应性有不同影响尚不清楚。我们的数据表明,炎症性心肌病中所见的炎症机制影响I型和III型胶原亚型的mRNA丰度。

相似文献

1
Differential myocardial abundance of collagen type I and type III mRNA in dilated cardiomyopathy: effects of myocardial inflammation.扩张型心肌病中心肌Ⅰ型和Ⅲ型胶原mRNA丰度的差异:心肌炎症的影响。
Cardiovasc Res. 1998 Jan;37(1):123-9. doi: 10.1016/s0008-6363(97)00217-4.
2
[Detection of enteroviral RNA in endomyocardial biopsies in inflammatory cardiomyopathy and idiopathic dilated cardiomyopathy].[炎症性心肌病和特发性扩张型心肌病心内膜心肌活检中肠道病毒RNA的检测]
Z Kardiol. 1998 Jun;87(6):443-52. doi: 10.1007/s003920050199.
3
Dilated cardiomyopathy is associated with significant changes in collagen type I/III ratio.扩张型心肌病与I型/III型胶原比例的显著变化有关。
Circulation. 1999 Jun 1;99(21):2750-6. doi: 10.1161/01.cir.99.21.2750.
4
Collagen content, but not the ratios of collagen type III/I mRNAs, differs among hypertensive, alcoholic, and idiopathic dilated cardiomyopathy.胶原含量在高血压性、酒精性和特发性扩张型心肌病中有所不同,但Ⅲ型/Ⅰ型胶原mRNA的比率并无差异。
Braz J Med Biol Res. 2008 Dec;41(12):1098-104. doi: 10.1590/s0100-879x2008001200009.
5
Fibrosis of extracellular matrix is related to the duration of the disease but is unrelated to the dynamics of collagen metabolism in dilated cardiomyopathy.细胞外基质纤维化与疾病持续时间有关,但与扩张型心肌病中胶原代谢的动态变化无关。
Inflamm Res. 2016 Dec;65(12):941-949. doi: 10.1007/s00011-016-0977-3. Epub 2016 Aug 11.
6
Endomyocardial miR-133a levels correlate with myocardial inflammation, improved left ventricular function, and clinical outcome in patients with inflammatory cardiomyopathy.心肌内 miR-133a 水平与炎症性心肌病患者的心肌炎症、左心室功能改善和临床结局相关。
Eur J Heart Fail. 2016 Dec;18(12):1442-1451. doi: 10.1002/ejhf.579. Epub 2016 Jun 13.
7
[Mechanisms of extracellular matrix remodeling in dilated cardiomyopathy].[扩张型心肌病细胞外基质重塑的机制]
Herz. 2002 Nov;27(7):677-82. doi: 10.1007/s00059-002-2413-4.
8
Immunopathogenesis of dilated cardiomyopathy. Evidence for the role of TH2-type CD4+T lymphocytes and association with myocardial HLA-DR expression.扩张型心肌病的免疫发病机制。TH2 型 CD4 + T 淋巴细胞作用的证据以及与心肌 HLA - DR 表达的关联。
J Clin Immunol. 2006 Jan;26(1):33-9. doi: 10.1007/s10875-006-7585-x.
9
Myocardial osteopontin expression is associated with collagen fibrillogenesis in human dilated cardiomyopathy.
Eur J Heart Fail. 2005 Aug;7(5):755-62. doi: 10.1016/j.ejheart.2004.10.019.
10
[Dilated cardiomyopathy--a chronic myocarditis? Immunohistological characterization of lymphocytic infiltrates].[扩张型心肌病——一种慢性心肌炎?淋巴细胞浸润的免疫组织学特征]
Herz. 1992 Apr;17(2):97-106.

引用本文的文献

1
Circulating collagen type I fragments as specific biomarkers of cardiovascular outcome risk: Where are the opportunities?循环I型胶原片段作为心血管结局风险的特异性生物标志物:机遇何在?
Matrix Biol. 2025 May;137:19-32. doi: 10.1016/j.matbio.2025.03.001. Epub 2025 Mar 2.
2
The Effect of β-Blocker Eye Drops on Pulse Rate, Ocular Blood Flow, and Glaucoma Progression: A Retrospective Longitudinal Study.β受体阻滞剂眼药水对脉搏率、眼血流和青光眼进展的影响:一项回顾性纵向研究。
Adv Ther. 2024 Feb;41(2):730-743. doi: 10.1007/s12325-023-02762-0. Epub 2024 Jan 2.
3
Ameliorating impaired cardiac function in myocardial infarction using exosome-loaded gallic-acid-containing polyurethane scaffolds.
使用负载外泌体的含没食子酸聚氨酯支架改善心肌梗死中受损的心脏功能。
Bioact Mater. 2023 Nov 24;33:324-340. doi: 10.1016/j.bioactmat.2023.11.009. eCollection 2024 Mar.
4
Altered Expression of ORAI and STIM Isoforms in Activated Human Cardiac Fibroblasts.激活的人心肌成纤维细胞中 ORAI 和 STIM 亚型的表达改变。
Physiol Res. 2021 Nov 30;70(Suppl 1):S21-S30. doi: 10.33549/physiolres.934771.
5
Cytokine-Mediated Alterations of Human Cardiac Fibroblast's Secretome.细胞因子介导的人心脏成纤维细胞分泌组的改变。
Int J Mol Sci. 2021 Nov 12;22(22):12262. doi: 10.3390/ijms222212262.
6
A Model for Studying the Biomechanical Effects of Varying Ratios of Collagen Types I and III on Cardiomyocytes.研究 I 型和 III 型胶原比例变化对心肌细胞生物力学影响的模型。
Cardiovasc Eng Technol. 2021 Jun;12(3):311-324. doi: 10.1007/s13239-020-00514-7. Epub 2021 Jan 11.
7
Natural Biomaterials for Cardiac Tissue Engineering: A Highly Biocompatible Solution.用于心脏组织工程的天然生物材料:一种高度生物相容性的解决方案。
Front Cardiovasc Med. 2020 Oct 23;7:554597. doi: 10.3389/fcvm.2020.554597. eCollection 2020.
8
Establishment of adult right ventricle failure in ovine using a graded, animal-specific pulmonary artery constriction model.使用分级的、动物特异性肺动脉缩窄模型建立绵羊成人右心室衰竭模型。
Animal Model Exp Med. 2020 Jun 14;3(2):182-192. doi: 10.1002/ame2.12124. eCollection 2020 Jun.
9
Identification of Novel miRNAs Involved in Cardiac Repair Following Infarction in Fetal and Adolescent Sheep Hearts.鉴定参与胎儿和青少年绵羊心脏梗死心脏修复的新型微小RNA
Front Physiol. 2020 Jun 10;11:614. doi: 10.3389/fphys.2020.00614. eCollection 2020.
10
The protective effects of liguzinediol on congestive heart failure induced by myocardial infarction and its relative mechanism.川芎嗪二醇对心肌梗死所致充血性心力衰竭的保护作用及其相关机制。
Chin Med. 2020 Jun 15;15:63. doi: 10.1186/s13020-020-00345-7. eCollection 2020.